 tumor-target chemotherapi lipid contrast medium macromolecular anticanc drug smanc renal cell carcinoma twenty-f patient renal cell carcinoma lipophil macromolecular drug poli stylene-co-mal acid neocarzinostatin smanc lipid contrast medium lipiodol drug renal arteri feed arteri patient common hepat arteri patient metastas liver radic nephrectomi procedur select arteri administr mg/ml smancs/lipiodol simpl week total dose smanc patient mg smanc lipiodol tumor tissu neovasculatur extracapillari space long time CT pattern oil contrast medium tumor high-dens area peripheri tumor central necrosi hyperviscos lipiodol lipiodol HV lipid contrast medium tumor lipiodol pronounc anticanc effect smancs/lipiodol HV smancs/lipiodol sever side effect myelosuppress unendur pain paralyt ileu chemotherapi great signific advanc renal cell carcinoma